<DOC>
	<DOCNO>NCT02672683</DOCNO>
	<brief_summary>The purpose study evaluate level expression 4 circulate microRNAs serum use RT-PCR . A pilote study cardiac transplant patient show expression microRNAs could discriminate patient histologically proven rejection patient display normal endomyocardial biopsy . The signature must confirm unselected patient stability evaluate accord clinical , biological immunological parameter include patient .</brief_summary>
	<brief_title>Non Invasive Detection Cardiac Allograft Rejection Circulating microRNAs</brief_title>
	<detailed_description>Heart transplantation available long-term treatment option patient terminal heart failure . Despite considerable progress immunosuppressive regimen , allograft rejection remain major cause graft loss . Majority cardiac allograft rejection asymptomatic . Only severe rejection go along cardiac dysfunction . This clinical latency make cardiac rejection diagnostic difficult rule modality detection cardiac rejection . The cornerstone rejection diagnosis post-transplant follow-up relies endomyocardial biopsy ( EMB ) classical histopathology assessment . Echocardiography MRI neither sensitive specific enough replace EMB . Majority transplant center thus evaluate rejection use iterative protocol biopsy . These cardiac allograft monitoring protocol heavy , 15 20 EMB first year transplantation 1 2 EMB year first year . EMB invasive procedure low zero risk severe adverse event . Repetition EMB associate tricuspid regurgitation due valvular complication . Moreover incidence cardiac rejection explain cost-effectiveness EMBs : 50 70 % biopsy normal . The goal thus detect rejection blood measure expression level 4 circulate microRNAs patient ' serum RT-PCR . The seric expression level 4 circulate microRNAs compare histopathological diagnosis make concomitant endomyocardial biopsy .</detailed_description>
	<criteria>Patients cardiac transplant time inclusion Patients transplant less 10 year annual followup Patients biopsy evaluation followup , month 1 , 3 , 6 , 12 ( newly transplant ) annually ( newly already transplanted patient ) concomitant routine blood work Patients oppose study Patients assessment antidonor specific antibody study period Patients multiorgan transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>